LEADER 03491nam  22004815  450 
001 9910349556803321
005 20200702115406.0
010   $a3-030-22258-6
024 7 $a10.1007/978-3-030-22258-1
035   $a(CKB)4100000008869923
035   $a(MiAaPQ)EBC5844344
035   $a(DE-He213)978-3-030-22258-1
035   $a(PPN)238492109
035   $a(EXLCZ)994100000008869923
100   $a20190730d2019      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aIntrahepatic Cholangiocarcinoma $eDiagnosis and Management /$fedited by Timothy M. Pawlik, Jordan M. Cloyd, Mary Dillhoff
205   $a1st ed. 2019.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2019.
215   $a1 online resource (221 pages)
311   $a3-030-22257-8 
327   $aEpidemiology and Risk Factors -- Clinical Presentation and Diagnosis -- Staging and Prognosis -- Imaging -- Surgical Treatment -- Management of the Nodal Basin -- Pathologic Assessment -- Systemic Therapy -- Percutaneous Ablation -- Transarterial Therapies -- Radiotherapy -- Molecular Pathogenesis: From Inflammation And Cholestasis To A Microenvironment-Driven Tumor -- Clinical Trials and Novel/Emerging Treatment.
330   $aThis book provides a comprehensive review of the epidemiology, molecular pathogenesis, diagnosis and treatment of intrahepatic cholangiocarcinoma (ICC). It brings together an impressive group of international experts in cholangiocarcinoma research and clinical care. The book was organized and written to aid the clinician?s understanding of emerging research in cholangiocarcinoma and its application to the clinical care of patients with ICC. Each chapter details the scientific evidence to support clinical decisions that are needed to care for these complex patients. Focused chapters detail the epidemiology, diagnostic evaluation, as well as staging and prognosis of this disease. In addition to dedicated chapters on surgical management of ICC, a broad emphasis on locoregional therapies, including percutaneous ablation and transarterial therapies, is included. An up-to-date overview of the molecular pathogenesis and pathological assessment of ICC is detailed prior to chapters focusing on systemic chemotherapy and emerging novel therapy options. Intrahepatic Cholangiocarcinoma is not only an invaluable resource for many as they seek to provide the best multidisciplinary cancer care to patients with ICC, but also an opportunity to identify new avenues of scientific discovery that lead to significant advances in the diagnosis and management of ICC.
606   $aSurgery
606   $aSurgical oncology
606   $aGeneral Surgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H59044
606   $aSurgical Oncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H59150
615  0$aSurgery.
615  0$aSurgical oncology.
615 14$aGeneral Surgery.
615 24$aSurgical Oncology.
676   $a616.99436
702   $aPawlik$b Timothy M$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aCloyd$b Jordan M$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aDillhoff$b Mary$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910349556803321
996   $aIntrahepatic Cholangiocarcinoma$91736789
997   $aUNINA